Medical Device Reporting Requirements for Manufacturers Final Guidance
Duration: 60 Minutes
This webinar explains the MDR regulation considering the new information contained in the Guidance and describes a compliant MDR procedure. Areas covered will include death, injury and mal-function reporting requirements, record keeping requirements, report timing, clarification of the term ‘becoming aware’ and clarification of reporting using electronic form 3500A.
Objectives of the Presentation
Why Should you Attend
- MDR regulation
- Reporting requirements
- Manufacturer reporting requirements
- Written procedures
- Recordkeeping and public disclosure
- Specific issues and situations
- Malfunction reporting
- Report timing
- When do you "become aware?"
In the United States, the Food and Drug Administration (FDA) Medical Device Reporting (MDR) regulations have required firms who have received complaints of device malfunctions, serious injuries or deaths associated with medical devices to notify FDA of the incident. MDR is the mechanism for the FDA to receive significant medical device adverse events from manufacturers, importers and user facilities, so they can be detected and corrected quickly. To achieve compliance and to remain compliant, it is critical to understand how to define, document and implement the MDR procedure to survive FDA inspections - avoiding FDA 483s and warning letters.
This webinar is aimed at helping device industry to understand, New FDA guidance which was issued in November 2016, explaining and clarifying the existing MDR regulation. Many of the details of the MDR regulation were unclear and ambiguous and resulted in non-conformances. This new Guidance attempts to eliminate confusion.
Who will Benefit
- Clinical Affairs
- Regulatory Affairs
- Complaint and Risk Management Personnel
- Senior Management
- Other interested parties
FDA, in November 2016, issued Guidance explaining and clarifying the existing MDR regulation. Many of the details of the MDR regulation were unclear and ambiguous and resulted in non-conformances. This new Guidance attempts to eliminate confusion.